Compliance with the EU FMD Directive
Challenges for data management
Fachthemen
The fast-approaching deadline for compliance with the EU Falsified Medicines Directive (FMD) is leaving many pharmaceutical companies and supply chain partners to face the harsh reality of implementing compliance strategies in a shortening timeframe. Hand-in-hand with compliance comes the extensive data management requirements that demand the generation and sharing of new types of data never previously managed by the industry. As a result, successful data management strategies need to go beyond simply achieving compliance and look to take advantage of the process enhancements available.
This article explores the challenges linked to implementing a master data management (MDM) strategy to meet serialisation requirements and the importance of collaboration across the supply chain to ensure data security and integrity. It also offers practical recommendations for dealing with the vast amount of data that will soon be created in the push for FMD compliance.
 | Manfred Voglmaier is vice president of sales at TraceLink for the DACH region. He is an experienced executive manager in sales and business development of enterprise-class technology solutions with more than 20 years of experience in the life sciences industry. Since joining TraceLink in 2017, he has been pivotal in the company’s growth in sales in the DACH regions. Manfred’s experience includes leading European sales teams and delivering technical sales, consulting and partner management services to the life sciences industry. Before joining TraceLink, he led the EMEA sales team for Systech |
